These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34534860)

  • 1. Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery.
    Lin D; Feng X; Mai B; Li X; Wang F; Liu J; Liu X; Zhang K; Wang X
    Biomaterials; 2021 Oct; 277():121124. PubMed ID: 34534860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
    Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
    Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances of bacteria-based delivery systems for modulating tumor microenvironment.
    Li S; Yue H; Wang S; Li X; Wang X; Guo P; Ma G; Wei W
    Adv Drug Deliv Rev; 2022 Sep; 188():114444. PubMed ID: 35817215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications.
    Dróżdż M; Makuch S; Cieniuch G; Woźniak M; Ziółkowski P
    Life Sci; 2020 Nov; 261():118296. PubMed ID: 32822716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.
    Sun Y; Li Y; Shi S; Dong C
    Molecules; 2021 May; 26(9):. PubMed ID: 34062992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
    Sia CS; Lim HP; Tey BT; Goh BH; Low LE
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in bacteria-mediated cancer therapy.
    Liang S; Wang C; Shao Y; Wang Y; Xing D; Geng Z
    Front Bioeng Biotechnol; 2022; 10():1026248. PubMed ID: 36312554
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
    Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacteria-mediated cancer therapies: opportunities and challenges.
    Yang M; Yang F; Chen W; Liu S; Qiu L; Chen J
    Biomater Sci; 2021 Sep; 9(17):5732-5744. PubMed ID: 34313267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteria and Bacterial Components as Natural Bio-Nanocarriers for Drug and Gene Delivery Systems in Cancer Therapy.
    Zong R; Ruan H; Liu C; Fan S; Li J
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell/Bacteria-Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy.
    Pan H; Zheng M; Ma A; Liu L; Cai L
    Adv Mater; 2021 Dec; 33(50):e2100241. PubMed ID: 34121236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models.
    Haider T; Sandha KK; Soni V; Gupta PN
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111229. PubMed ID: 32806313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
    Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
    Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision strategies for cancer treatment by modifying the tumor-related bacteria.
    Lu H; Wang Q; Liu W; Wen Z; Li Y
    Appl Microbiol Biotechnol; 2021 Aug; 105(16-17):6183-6197. PubMed ID: 34402938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.